Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-26-031274
Filing Date
2026-03-18
Accepted
2026-03-18 17:26:35
Documents
80
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mrkr-20251231x10k.htm   iXBRL 10-K 1998249
2 EX-14.1 mrkr-20251231xex14d1.htm EX-14.1 35499
3 EX-21.1 mrkr-20251231xex21d1.htm EX-21.1 1498
4 EX-23.1 mrkr-20251231xex23d1.htm EX-23.1 1976
5 EX-23.2 mrkr-20251231xex23d2.htm EX-23.2 1980
6 EX-31.1 mrkr-20251231xex31d1.htm EX-31.1 11084
7 EX-31.2 mrkr-20251231xex31d2.htm EX-31.2 11094
8 EX-32.1 mrkr-20251231xex32d1.htm EX-32.1 5046
9 EX-32.2 mrkr-20251231xex32d2.htm EX-32.2 5050
10 GRAPHIC mrkr-20251231x10k001.jpg GRAPHIC 13424
11 GRAPHIC mrkr-20251231x10k002.jpg GRAPHIC 44015
12 GRAPHIC mrkr-20251231x10k003.jpg GRAPHIC 48497
13 GRAPHIC mrkr-20251231x10k004.jpg GRAPHIC 56470
14 GRAPHIC mrkr-20251231x10k005.jpg GRAPHIC 57751
15 GRAPHIC mrkr-20251231x10k006.jpg GRAPHIC 102235
16 GRAPHIC mrkr-20251231x10k007.jpg GRAPHIC 101645
17 GRAPHIC mrkr-20251231x10k008.jpg GRAPHIC 79529
18 GRAPHIC mrkr-20251231x10k009.jpg GRAPHIC 57317
  Complete submission text file 0001104659-26-031274.txt   8635566

Data Files

Seq Description Document Type Size
19 EX-101.SCH mrkr-20251231.xsd EX-101.SCH 45270
20 EX-101.CAL mrkr-20251231_cal.xml EX-101.CAL 39066
21 EX-101.DEF mrkr-20251231_def.xml EX-101.DEF 179797
22 EX-101.LAB mrkr-20251231_lab.xml EX-101.LAB 425234
23 EX-101.PRE mrkr-20251231_pre.xml EX-101.PRE 318228
84 EXTRACTED XBRL INSTANCE DOCUMENT mrkr-20251231x10k_htm.xml XML 1055513
Mailing Address 2450 HOLCOMBE BLVD TMC PARTNERS OFFICE 1.311 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD TMC PARTNERS OFFICE 1.311 HOUSTON TX 77021 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37939 | Film No.: 26770583
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)